Refractory warts: topical or intralesional cidofovir options

Published Date: 02 Mar 2023

New research suggests that cidofovir may be a helpful option for tender joints or joints.

Read Full News

Latest News

US DOJ Closes Criminal Probe Into Abbott Over Baby Formula Plant, WSJ Reports

The U.S. Justice Department closed a criminal probe into Abbott Laboratories over its handling of a baby formula ⁠plant linked to potentially deadly bacteria and infant...

FDA Approves Risankizumab for Children With Psoriasis, PsA

The interleukin 23 inhibitor was approved for treating moderate-to-severe plaque psoriasis in adults in 2019 and for active psoriatic arthritis in adults in 2022.

Tattooed Skin: A Novel SSI Risk Factor in Spine Surgery

Tattooed skin at the operative site nearly triples the risk for surgical site infections in spine surgery, demanding individualised perioperative protocols.

Can Bimekizumab Match IL-23 Inhibitors in Psoriasis?

A retrospective study finds that bimekizumab yields comparable drug survival to interleukin-23 inhibitors after the failure of interleukin-17 inhibitors in patients with psoriasis.

Traveling in Europe: Should Mosquito Risks Be on Your Radar?

Travel medicine specialists say that mosquito protection deserves the same attention as sunscreen because vector-borne infections become more common in Europe.

To Heal Stubborn Wounds, Scientists Look to Nanomaterials

Slow-healing lesions — common in diabetics and burn victims — can lead to lingering infections that resist antibiotic treatment. A new approach using light-activated therapies may offer a solution.

Todays Updates

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

Combined Models With AI Improve Breast Cancer Prediction

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Todays Updates

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

Combined Models With AI Improve Breast Cancer Prediction

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Latest News

The U.S. Justice Department closed a criminal probe into Abbott Laboratories over its handling of a baby formula ⁠plant linked to potentially deadly bacteria and infant...

The interleukin 23 inhibitor was approved for treating moderate-to-severe plaque psoriasis in adults in 2019 and for active psoriatic arthritis in adults in 2022.

Tattooed skin at the operative site nearly triples the risk for surgical site infections in spine surgery, demanding individualised perioperative protocols.

A retrospective study finds that bimekizumab yields comparable drug survival to interleukin-23 inhibitors after the failure of interleukin-17 inhibitors in patients with psoriasis.

Travel medicine specialists say that mosquito protection deserves the same attention as sunscreen because vector-borne infections become more common in Europe.

Slow-healing lesions — common in diabetics and burn victims — can lead to lingering infections that resist antibiotic treatment. A new approach using light-activated therapies may offer a solution.

News All Time

Are Drug‑Resistant Infections Outpacing Industry Efforts?

High-quality research and proper antimicrobial stewardship can hold the key to mitigating antibiotic resistance.

Vulvar Melanoma Outcomes Worse With Surgery Delay

Surgical delays of 91 days and longer from diagnostic biopsy are linked to positive margins and worse survival in patients with early-stage vulvar melanoma, study finds.

Elicio Shares Slide After Pancreatic Cancer Vaccine Falls Short in Mid-stage Study

Elicio Therapeutics shares fell about 72% on Monday after the biotech firm's experimental pancreatic cancer vaccine ⁠failed to significantly extend the time patients lived...

Social Media Sunscreen Recipes Raise Safety Concerns

Homemade sunscreen recipes are gaining attention, but laboratory studies suggest they may reduce ultraviolet damage unevenly and fail against key sunburn markers.

Cutaneous Lupus Flares Peak During Late Perimenopause

Cutaneous lupus flares increase during late perimenopause and remain elevated after menopause, study finds.

Somatic Cancer Symptoms May Be Overattributed to Depression

Experts offer advice for treating symptoms of ovarian, breast, and other cancers that are not driven by depression and explain why it’s essential to discern the difference.

UKHSA: New Pandemic More Than 25% Likely Within 5 Years

Influenza and novel coronavirus top a new UKHSA threat register covering 22 risks, from dengue to drug-resistant infections.

Most OTC Vaginal Moisturizers Contain Contact Allergens

Over-the-counter vaginal and vulvar moisturizers often contain allergens, with inaccurate marketing claims, a study shows.

Secondary Syphilis Sign Shows Reliable Histologic Pattern

Condyloma lata in secondary syphilis shows consistent histopathologic findings that may help prevent misdiagnosis.

Drop Flare Fears to Fix Rheumatic Vaccination Gaps

Vaccination remains the best measure to protect immunosuppressed patients, but new evidence suggests a rethink of scheduling.

Takeda's AI-crafted Psoriasis Pill Tops Bristol Myers' Sotyktu in Head-to-head Trial

Japan's Takeda Pharmaceutical said on Thursday its experimental once-daily psoriasis pill, developed with the help of AI, outperformed Bristol ⁠Myers Squibb's approved drug...

Can Age-Old Chinese Therapy Reduce Insulin Needs in T2D?

Acupuncture may reduce insulin requirements to a greater extent than a sham treatment in adults with type 2 diabetes and overweight receiving insulin therapy, a trial suggests.

Golimumab Shows Benefit in Refractory HS

More than half of patients with treatment-refractory hidradenitis suppurativa achieve meaningful disease improvement with golimumab therapy in a study.

Psoriasis in Pregnancy: Study Supports Safety of Biologics

In pregnant women with psoriasis, biologic therapy is not linked to increased risk for adverse maternal or neonatal outcomes compared with unexposed patients, study finds.

How Can Canada Improve Access to Dermatologic Care?

The Canadian Dermatology Association proposes increasing residency spots, expanding technology, and integrating international graduates into the workforce.

Choosing a Journal: What Matters More Than Impact Factor?

Researchers weigh peer review, indexing, transparency, and audience reach alongside impact factor when deciding where to submit scientific work.

Recommended News For You

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

Patients face high out-of-pocket costs after incident cancer diagnosis

novel approach to test the toxicity of cancer drugs.

Loneliness and social isolation linked to heightened risk of death in those with cancer

Radiation therapy for patients with breast cancer

For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes

Recommended Articles For You

Strategic Directions in Oncology in the Digital Era 

Different Types of Blood Dyscrasias  

Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential 

Understanding Epoetin and Its Role in Treating Chronic Kidney Disease  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charting the Course: From Young Adult Leukemia Patient to Oncologist.

2.

The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.

3.

Early detection of breast cancer may be possible with AI-based mammography microcalcification detection and classification.

4.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.

5.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

1.

The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late

2.

Survivorship and Quality of Life in Modern Oncology Care

3.

Landmark Medical Oncology Trials Redefining Early Breast Cancer Management

4.

Organoids & Single-Cell Tools: Breakthroughs in Colorectal Cancer Research

5.

Harnessing Snake Venom in Hematology: From Toxins to Life-Saving Therapeutics

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

2.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

4.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases

5.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot